Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pheast Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Pheast Therapeutics

Pheast Therapeutics

Series A

Pheast Therapeutics: Innovating cancer immunotherapy with novel checkpoint therapies.

HQ
Palo Alto, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Pheast Therapeutics, founded with a mission to innovate cancer immunotherapy, focuses on developing novel checkpoint therapies that harness the innate immune system to combat cancer. The company is dedicated to creating treatments that target specific immune checkpoints, such as their lead candidate PHST001, an anti-CD24 macrophage checkpoint inhibitor. Pheast aims to revolutionize the cancer treatment landscape by enhancing the body's natural ability to fight tumors, targeting a market that includes patients with various forms of cancer.

Notable achievements for Pheast Therapeutics include raising $76 million in Series A funding and being featured as one of Nature Biotechnology’s top academic spinouts. The company has also unveiled promising preclinical data for PHST001, highlighting its potential in cancer immunotherapy. With significant backing from investors and recognition from industry leaders, Pheast Therapeutics is poised to make a substantial impact on the future of cancer treatment by advancing innovative therapies that leverage the immune system's power.

Pheast Therapeutics - Similar Companies

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

NextPoint Therapeutics logo

NextPoint Therapeutics

nextpointtx.com

Parthenon Therapeutics logo

Parthenon Therapeutics

parthenontx.com

Phanes Therapeutics logo

Phanes Therapeutics

phanesthera.com

DEM Biopharma logo

DEM Biopharma

dembiopharma.com

Ostentus Therapeutics logo

Ostentus Therapeutics

PineTree Therapeutics logo

PineTree Therapeutics

pinetreetx.com

Faeth Therapeutics logo

Faeth Therapeutics

Onchilles Pharma logo

Onchilles Pharma

Umoja Biopharma logo

Umoja Biopharma

Thunder Biotech logo

Thunder Biotech

thunderbiotech.com

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Palm Therapeutics logo

Palm Therapeutics

PNP Therapeutics logo

PNP Therapeutics

Partner Therapeutics logo

Partner Therapeutics

partnertx.com

Pheast Therapeutics - Quick Facts

Who are Pheast Therapeutics' competitors?

Companies similar to Pheast Therapeutics include Checkpoint Therapeutics, NextPoint Therapeutics, Parthenon Therapeutics and Phanes Therapeutics.

When was Pheast Therapeutics founded?

Pheast Therapeutics was founded in 2020.

Where is Pheast Therapeutics' headquarters located?

Pheast Therapeutics' headquarters is located in Palo Alto, CA, US.

When was Pheast Therapeutics' last funding round?

Pheast Therapeutics' most recent funding round was for $76M (USD) in April 2022.

How much has Pheast Therapeutics raised to-date?

As of Apr 26, 2022, Pheast Therapeutics has raised a total of $76M (USD).

How many employees does Pheast Therapeutics have?

Pheast Therapeutics has 23 employees as of Feb 5, 2024.

Pheast Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapies
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified